CXCR3 and neoplasm: Interestingly, Ncr1ΔCxcr3 mice displayed increased metastasis incidence at 15 days and increased tumor burden at 20 days postinjection, indicating a role for CXCR3+NKp46+ cells in protection from metastasis (Figure 8, A and B).